Article
Establishment of a second-generation transgenic marmoset model of polyglutamine disease recapitulating neurological symptoms and pathology
2025-03-13
Abstract excerpt
Neurodegenerative diseases, including polyglutamine diseases, remain a major clinical challenge, partly because of limited animal models that recapitulate human disease. Here, we describe a second-generation transgenic marmoset model of spinocerebellar ataxia 3 (SCA3), a polyglutamine disease, which stably expresses expanded CAG repeats in ATXN3 . All five offspring of the founder marmoset harbored the transgene...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b6b2bf42-e879-5be6-a9e3-4231140d0d6f
- DOI
- 10.1101/2025.03.12.642922
